Your browser doesn't support javascript.
loading
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
Cherifi, François; Da Silva, Angélique; Johnson, Alison; Blanc-Fournier, Cécile; Abramovici, Olivia; Broyelle, Antonin; Levy, Christelle; Allouache, Djelila; Hrab, Ioana; Segura, Carine; Morel, Adeline; Villemin, Maud; Boscher, Clémence; Dubot-Poitelon, Coraline; Rottier, Pauline; Lequesne, Justine; Emile, George.
Afiliação
  • Cherifi F; Department of Clinical Research, CLCC Francois Baclesse, Caen, France. francois.cherifi@gmail.com.
  • Da Silva A; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France. francois.cherifi@gmail.com.
  • Johnson A; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Blanc-Fournier C; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Abramovici O; Department of Pathology, CLCC Francois Baclesse, Caen, France.
  • Broyelle A; Department of Pathology, CLCC Oscar Lambret, Lille, France.
  • Levy C; Breast Cancer Unit, CLCC Oscar Lambret, Lille, France.
  • Allouache D; Department of Clinical Research, CLCC Francois Baclesse, Caen, France.
  • Hrab I; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Segura C; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Morel A; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Villemin M; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Boscher C; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Dubot-Poitelon C; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Rottier P; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Lequesne J; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
  • Emile G; Breast Cancer Unit, CLCC François Baclesse, Institut Normand du Sein, Caen, France.
BMC Cancer ; 22(1): 1081, 2022 Oct 20.
Article em En | MEDLINE | ID: mdl-36266623
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França